L-carnitine injections: FDA status, evidence and risks
As of October 15, 2026, levocarnitine (L-carnitine) injection is an FDA-approved prescription drug, sold as CARNITOR under NDA 020182, while acetyl-L-carnitine is a different substance that sits in Category 1 of FDA’s interim 503A compounding policy. Approval for its labelled uses does not make L-carnitine shots a proven fat-loss or energy treatment.
Status at a glance
| Check | Status as of October 15, 2026 | Source · read date |
|---|---|---|
| FDA approval | Levocarnitine injection approved: Drugs@FDA lists “CARNITOR LEVOCARNITINE INJECTABLE;INJECTION Prescription” (NDA 020182). | Drugs@FDA · read October 15, 2026 |
| 503A interim category | Levocarnitine is an approved-drug ingredient. Acetyl-L-carnitine is in Category 1 (“Acetyl L Carnitine/Acetyl-L- carnitine Hydrochloride”), categories PDF updated May 14, 2026. | FDA · read October 15, 2026 |
| FDA advisory committee (PCAC) | None found for 2025–2026. | FDA · read October 15, 2026 |
| WADA 2026 Prohibited List | Not named. Method M2.2 prohibits IV infusions over 100 mL per 12 hours outside hospital care. | World Anti-Doping Agency · read October 15, 2026 |
| FDA warning letters, 2026 | None found naming L-carnitine. | FDA warning letters · read October 15, 2026 |
| WADA 2027 list | Not named on the 2027 list (in force January 1, 2027); the M2.2 limit on IV infusions over 100 mL per 12 hours is unchanged. | World Anti-Doping Agency · read October 15, 2026 |
Two forms, two regulatory statuses
L-carnitine (levocarnitine) is a nutrient the body uses to move fatty acids into mitochondria, where they are burned for energy. It is the active ingredient of CARNITOR, an FDA-approved prescription injection. Because it is a component of an approved drug, it does not depend on FDA’s interim categories.
Acetyl-L-carnitine is a related but separate substance. It has no approved drug product that we found, and FDA lists it in Category 1, so licensed 503A pharmacies may compound it under enforcement discretion. Ask which one you are being prescribed.
We did not re-read the CARNITOR label for this update, so we do not restate its approved indications here; you can read them through Drugs@FDA. What matters for most readers: wellness clinics sell L-carnitine shots for fat loss and energy, and those are not the reason the drug was approved.
Human evidence
We have not re-read the clinical literature on L-carnitine injections for weight loss or energy and cite no trial. In general, the evidence that extra carnitine helps people who are not carnitine-deficient lose fat is weak. We make no claim of benefit.
Animal and laboratory evidence
Carnitine’s role in fat metabolism is well described in laboratory and animal research. A role in metabolism does not mean that adding more burns more fat in a healthy person.
Risks
Injections and drips carry the usual risks of compounded sterile products and of the setting in which they are given. If you are given the approved product, its label lists the warnings; ask the prescriber to go through them. Athletes should watch the WADA 100 mL IV rule.
Legal sourcing: who can supply it
A prescription for levocarnitine can be filled with the approved product or, where justified, compounded by a licensed pharmacy from an approved-drug ingredient. Acetyl-L-carnitine can be compounded by a licensed 503A pharmacy under Category 1. Ask the clinic to name its pharmacy. See compounding routes and MIC/B12 injections, often sold alongside.
The lawful route for a prescription peptide in the United States is a licensed clinician who examines you and writes a prescription, filled by a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility that is allowed to use that substance. Websites that sell peptides “for research use only” or “not for human consumption” are not a lawful source of medicine for people. On August 24, 2026, FDA sent warning letters to five such sellers — Peptide Partners, Peak Performance Peptides, Royal Peptides, NuScience Peptides and Tex Peptides — calling their products unapproved new drugs. FDA wrote that the research-use labels did not change its view because the websites showed the products were meant for human use.
October 2026: what changed
- April 2026 — Category 2 withdrawals. FDA moved BPC-157, TB-500, CJC-1295, ipamorelin, AOD-9604, injectable GHK-Cu and other peptides off its Category 2 list after the nominators withdrew them. FDA lists them as “nominated but withdrawn” (page current as of April 22, 2026). They were not moved into Category 1.
- July 23–24, 2026 — advisory committee. FDA’s Pharmacy Compounding Advisory Committee reviewed BPC-157, KPV, TB-500, MOTs-C, emideltide (DSIP), Semax and Epitalon. FDA staff proposed not adding BPC-157 or TB-500. A law-firm account reports the committee voted 8–6 (one abstention) to recommend BPC-157, KPV and TB-500 (McDermott, July 27, 2026). A vote is advice; FDA has taken no final action.
- October 14–15, 2026 — interim access policy under White House review. The OIRA review site lists “Interim Access Policy for Compounding Using Certain Peptides” from HHS/FDA (RIN 0910-ZD94, stage: Notice), received October 14, 2026 and pending review; no text has been published (reginfo.gov). Reuters reported the filing on October 15 (Reuters), and the AP, citing two people, said it would let pharmacies make some popular peptides, including BPC-157. Which peptides, on what terms and from when are not public. Our running table: peptide legal status 2026.
For L-carnitine: nothing changed in 2026. Levocarnitine remains an approved drug and acetyl-L-carnitine remains in Category 1. The interim policy reported on October 15 concerns peptides, and L-carnitine is not one.
Frequently asked questions
Is L-carnitine FDA-approved?
Levocarnitine injection is. Drugs@FDA lists CARNITOR (levocarnitine) injection as a prescription product under NDA 020182. Acetyl-L-carnitine is a separate substance with no approved product we found; it is in Category 1 of FDA’s interim compounding policy.
Do L-carnitine shots help with weight loss?
We found no strong evidence that they do in people who are not carnitine-deficient, and weight loss is not why the approved drug exists. We have not re-read the literature for this update. Treat fat-burning claims as marketing.
What is the difference between L-carnitine and acetyl-L-carnitine?
They are related but different substances. Levocarnitine is the active ingredient of an approved injection. Acetyl-L-carnitine has no approved product we found and is compounded under FDA’s Category 1 enforcement discretion.
Is L-carnitine banned in sport?
L-carnitine is not named on WADA’s 2026 Prohibited List. However, IV infusions or injections over 100 mL in 12 hours are prohibited under method M2.2 unless received in hospital care, surgery or clinical investigations.
Sources
- Drugs@FDA — NDA 020182, CARNITOR (levocarnitine) injection (read October 15, 2026)
- FDA — Interim policy categories for 503A and 503B bulk drug substances (PDF, updated May 14, 2026) (read October 15, 2026)
- FDA — Bulk drug substances used in compounding under section 503A (page current as of May 14, 2026) (read October 15, 2026)
- World Anti-Doping Agency — Prohibited List (2026 list in force) (read October 15, 2026)
- World Anti-Doping Agency — 2026 Prohibited List (PDF) (read October 15, 2026)
- World Anti-Doping Agency — 2027 Prohibited List (published September 21, 2026; in force January 1, 2027) (read October 15, 2026)